Analyst Research

Report Title Price
ASTEX PHARMACEUTICALS INC (ASTX) 12-months forecast
Provider: Pechala's Reports
$15.00
Buy
Astex Pharmaceuticals Inc: Business description, financial summary, 3yr and interim financials, key statistics/ratios and historical ratio analysis.
Provider: Reuters Investment Profile
$20.00
Buy
Thomson Reuters Stock Report - ASTEX PHARMACEUTICALS INC (ASTX-O)
Provider: Thomson Reuters Stock Report
$25.00
Buy
ValuEngine Detailed Valuation Report for ASTX
Provider: ValuEngine, Inc.
$127.00
Buy

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

» More Analyst Research

Astex Pharmaceuticals, Inc. Issues FY 2011 Net Income Guidance-Conference Call


Monday, 31 Oct 2011 08:30am EDT 

Astex Pharmaceuticals, Inc. announced that for fiscal 2011, it expects net income based on level of anticipated revenue and expenses to be approximately $4 million. 

Latest Developments for Astex Pharmaceuticals Inc

Latest Key Developments in Biotechnology

Company Quote

Astex Pharmaceuticals Inc
(ASTX.O)
5.36
0.24 +4.69%
24 May 2013